About Genova Diagnostics
Genova Diagnostics is a Healthcare company based in Asheville (United States) founded in 1986, and was acquired by LLCP in November 2013. It operates as a chronic disease diagnosis through specialized testing is offered. It operates on a Professional Services and Direct-to-Consumer (D2C) model. Its website gdx.net draws about 138 thousand monthly visits. Genova Diagnostics offers products and services including GI Effects Comprehensive Stool Profile, NutrEval, and Endo+. Its focus areas include Diagnostics and Personalized Health Testing. Its legal entity is Genova Diagnostics (GDX). Its competitors include Omniome, Tessera Therapeutics, HitGen, Phase Genomics and Hexagon Bio and 5 more; 8 of its 10 listed competitors have raised funding.
Company details
Personalized health assessments are provided by Genova Diagnostics through advanced diagnostic testing. Focus is placed on gut health, nutrition, hormonal balance, immune function, and genomics. Comprehensive panels and individual add-ons are designed to identify root causes of chronic health issues. Clinical data is utilized to offer actionable recommendations tailored to unique biological profiles. Services cater to both healthcare professionals and individuals seeking wellness solutions. Testing can often be completed from home, with results accessible online for review with physicians.
- Investors
- Acquired byLLCP
(Nov 2013)
Products & Services of Genova Diagnostics
Genova Diagnostics offers a comprehensive portfolio of products and services, including GI Effects Comprehensive Stool Profile, NutrEval, and Endo+.
Insight into digestive function and intestinal microbiome is provided.
Nutritional needs and toxic exposures are assessed accurately.
Hormonal balance and related issues are evaluated thoroughly.
Apps and channels of Genova Diagnostics
its YouTube channel Genova Diagnostics has 9.09K subscribers and 30 videos.
Videos from Genova Diagnostics
The most watched videos on Genova Diagnostics's YouTube channel, Genova Diagnostics (9.09K subscribers). Click a video to play it here.
More on Genova Diagnostics.
Investors in Genova Diagnostics
Genova Diagnostics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Levine Leichtman Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A middle market private equity firm with structured investment strategies. | 1984 | llcp.com | Beverly Hills, United States |
Investor details for Genova Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Genova Diagnostics
33 people are tracked at Genova Diagnostics (14 in leadership, 19 in team).
| Name | Role | Group |
|---|---|---|
Earlene Clark | Chief Compliance Officer | Leadership |
Patricia Devers | Chief Clinical Officer | Leadership |
Ceco Ivanov | Chief Information Officer | Leadership |
Todd Alston | Director Of Recruiter And Community Engagement | Leadership |
Jeffrey Ledford | CEO | Leadership |
Jeff Ellis | Chief Commerical Officer | Leadership |
Craig Thiel | Chief Financial Officer | Leadership |
Amy Peacebrewer | Chief Clinical & Scientific Officer | Leadership |
Bob David | Lab Director | Leadership |
Teresa McKenzie | Director Of Human Resources | Leadership |
Kim Darr | National Sales Director | Leadership |
Melissa Robinson | Marketing Director | Leadership |
David Barrett | Marketing Creative Director | Leadership |
Michael Chapman Nd | Director Of Product Innovation | Leadership |
Kurt Jarrett | Software Developer | Team |
Jamesia Veazey Orelaja M.s, Mcm (ASCP) | Clinical Lab Technologist | Team |
Bob Rountree | Speaker's Bureau | Team |
Hege Løvereide | Customer Service And Finance Assistant | Team |
Amanda Crowder | Laboratory Technician | Team |
Allie Larkin | Chemical Laboratory Tech II | Team |
13 more people are available in the full profile.
Complete people profiles for Genova Diagnostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Genova Diagnostics
2 dated milestones of Genova Diagnostics across 27 years, from founding to its latest funding, stage changes and deals.
- Founded Genova Diagnostics is founded.
- Exit Acquired by LLCP.
Competitors of Genova Diagnostics
Genova Diagnostics has 10 listed competitors in our database, 8 of them funded. They include Omniome, Tessera Therapeutics, HitGen, Phase Genomics and Hexagon Bio, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| omniome.com | 2013 | San Diego, United States | $160.23M | 164 | Genome sequencing platform is provided for clinical diagnostics. | |
| tesseratherapeutics.com | 2017 | Cambridge, United States | $610M | 149 | New genome engineering technology is provided for treating multiple diseases. | |
| hitgen.com | 2012 | Lanzhou, China | $39.11M | – | DNA-encoded libraries are developed for drug discovery applications. | |
| phasegenomics.com | 2015 | Seattle, United States | $5.75M | 19 | Laboratory and computational services for DNA proximity analysis are provided. | |
| hexagonbio.com | 2017 | Menlo Park, United States | $205.6M | 34 | Bioinformatics tools are provided for analyzing microbial genomic sequencing data. | |
| novogene.com | 2011 | Beijing, China | $75M | 141 | Genomic services and solutions with NGS expertise are provided. | |
| novellusdx.com | 2011 | Jerusalem, Israel | $85.5M | – | Developer of technology for precision cancer diagnosis and therapies | |
| bgi.com | 1999 | Shenzhen, China | – | 25 | BGI is engaged in genomics and precision medicine solutions. | |
| genewiz.com | 1999 | South Plainfield, United States | – | 452 | Genomic services are provided for the life sciences industry. | |
| seqone.com | 2017 | Montpellier, France | $48.79M | – | Bioinformatics tools for genome sequencing data analysis are provided. |
Detailed competitors of Genova Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Genova Diagnostics
The website of Genova Diagnostics (gdx.net) receives about 138.4K visits a month and ranks #247,946 among all websites worldwide, #8,361 in Health.
- Monthly visits138.4K
▲ 3.3% vs previous month
- Unique visitors50K
per month
- Global rank#247,946
among all websites
- Category rank#8,361
Health · Health
- Bounce rate35%
- Pages per visit3.8
- Average visit3 min 00 sec
- DevicesDesktop 52% Β· Mobile 48%
Websites whose visitors overlap most with Genova Diagnostics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| rupahealth.com | 100% | 705.4K | #83,610 | View details | |
abramsroyalpharmacy.com | abramsroyalpharmacy.com | 100% | – | – | β |
| accessmedlab.com | 100% | 30.7K | #756,972 | View details | |
bodylogicmd.com | bodylogicmd.com | 100% | – | #522,415 | β |
orthomolecularproducts.com | orthomolecularproducts.com | 100% | – | #288,375 | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 40 similar websites and full traffic analytics for Genova Diagnostics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
10 companies that operate in the same segment as Genova Diagnostics (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 562 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Genova Diagnostics
Complete news archive for Genova Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genova Diagnostics
Genova Diagnostics was founded in 1986.
Genova Diagnostics is headquartered in Asheville, United States. It is registered at Asheville, North Carolina, United States.
Personalized health assessments are provided by Genova Diagnostics through advanced diagnostic testing. Focus is placed on gut health, nutrition, hormonal balance, immune function, and genomics. Comprehensive panels and individual add-ons are designed to identify root causes of chronic health issues. Clinical data is utilized to offer actionable recommendations tailored to unique biological profiles. Services cater to both healthcare professionals and individuals seeking wellness solutions. Testing can often be completed from home, with results accessible online for review with physicians.
Genova Diagnostics's top competitors include Tessera Therapeutics, Novogene Corporation and Phase Genomics.
Genova Diagnostics offers GI Effects Comprehensive Stool Profile, NutrEval, and Endo+.
Genova Diagnostics has 1 investor. Key investors include Levine Leichtman Capital Partners.
Genova Diagnostics operates through Genova Diagnostics (Gdx).
Yes. Genova Diagnostics was acquired by LLCP in November 2013.
The website of Genova Diagnostics receives about 138 thousand visits a month and ranks #247,946 among all websites worldwide.

